Semaglutide (brand name Wegovy) is an FDA-approved medication used for chronic weight management. It works by mimicking a natural hormone (GLP-1) that helps regulate appetite and blood sugar, making you feel fuller longer and reducing overall food intake.

Yes! The FDA approved Semaglutide (Wegovy) in 2021 for adults with obesity or overweight (BMI ≥27) who have at least one weight-related condition (like high blood pressure, high cholesterol, or type 2 diabetes). In 2023, the FDA expanded approval to include use in teens 12+ and for reducing cardiovascular risk in certain adults.

At Narrow Path Medical, Semaglutide is provided via telehealth consultations and delivered to you for self-injection at home. We give you clear instructions and ongoing support to help you safely and confidently administer your weekly injections.

Sustainable weight loss when combined with healthy habits

Appetite control and reduced cravings

Improved metabolic health, including better blood sugar regulation

Many users also report increased energy and more motivation for daily activity.

Semaglutide is generally well-tolerated, but like any medication, it can cause side effects. Common ones include nausea, mild stomach upset, or fatigue, especially during dose increases. Rare but serious risks include pancreatitis or thyroid concerns, which we screen for during your initial consult. Our licensed medical team will determine if it’s the right fit for you.